WARF VENTURES
WARF Ventures provides seed and growth funding to early-stage startups that are commercializing the University of Wisconsin-Madison and Morgridge Institute for Research technologies. Our strong connections to local, regional, and national venture capital communities mean WARF Ventures can help portfolio companies access additional support, reach early milestones, and attract follow-on investments.
WARF VENTURES
Status:
Active
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-08 | Innervace | WARF Ventures investment in Series A - Innervace | 40 M USD |
| 2022-09-06 | Elephas | WARF Ventures investment in Series B - Elephas | 41.5 M USD |
| 2022-03-02 | Quiver Quantitative | WARF Ventures investment in Seed Round - Quiver Quantitative | 2 M USD |
| 2022-01-17 | Transfur | WARF Ventures investment in Pre Seed Round - Transfur | N/A |
| 2021-09-15 | Elephas | WARF Ventures investment in Series A - Elephas | 20 M USD |